| |
| |
|
| Insider
Information: |
Seidenberg Beth C |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
11 |
|
| Direct
Shares |
320,491 |
|
|
Indirect Shares
|
23,818,703 |
|
|
| Direct
Value |
$5,542,525 |
|
|
|
Indirect Value
|
$61,686,288 |
|
|
| Total
Shares |
24,139,194 |
|
|
| Total
Value |
$67,228,813 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
0.0
|
| Percentage
Gain/Loss : |
 -69.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amgen Inc |
AMGN |
Sr VP, Dev & Chief Med... |
2004-12-31 |
15,343 |
2004-01-14 |
0 |
Premium* |
|
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2006-05-03 |
0 |
2006-05-03 |
3,000 |
Premium* |
|
|
Tesaro, Inc. |
TSRO |
Director |
2019-01-22 |
0 |
2019-01-22 |
0 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
Director |
2019-06-30 |
8,481 |
2019-06-30 |
4,115,555 |
Premium* |
|
|
Atara Biotherapeutics, Inc. |
ATRA |
|
2023-05-31 |
115,689 |
2023-05-31 |
1,877,044 |
Premium* |
|
|
Armo Biosciences Inc |
ARMO |
Director |
2018-01-30 |
0 |
2018-06-22 |
0 |
Premium* |
|
|
Progyny, Inc. |
PGNY |
Director |
2023-06-23 |
36,210 |
2023-06-23 |
5,302,521 |
Premium* |
|
|
Vera Therapeutics, Inc. |
VERA |
Director |
2021-05-18 |
0 |
2023-03-28 |
1,946,995 |
Premium* |
|
|
Acelyrin, Inc. |
SLRN |
Director, 10% Owner |
2023-05-09 |
60,000 |
2023-05-09 |
9,790,729 |
Premium* |
|
|
Sagimet Biosciences Inc. |
SGMT |
Director |
2023-07-18 |
84,768 |
2023-07-18 |
46,875 |
Premium* |
|
|
Kyverna Therapeutics |
KYTX |
|
2024-02-12 |
0 |
2024-02-12 |
735,984 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNY |
Progyny, Inc. |
Director |
– • – |
2019-10-29 |
4 |
A |
$0.00 |
$0 |
I/I |
16,902,868 |
17,621,896 |
0 |
- |
|
| SLRN |
Acelyrin, Inc. |
Director |
– • • |
2023-05-09 |
4 |
A |
$0.00 |
$0 |
I/I |
8,540,729 |
8,540,729 |
0 |
- |
|
| KYTX |
Kyverna Therapeutics |
|
– • • |
2024-02-12 |
4 |
A |
$0.00 |
$0 |
I/I |
4,523,924 |
735,984 |
0 |
- |
|
| ARMO |
Armo Biosciences Inc |
Director |
– • • |
2018-01-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,266,683 |
4,266,683 |
0 |
- |
|
| ARMO |
Armo Biosciences Inc |
Director |
– • – |
2018-06-22 |
4 |
D |
$50.00 |
$213,334,150 |
I/I |
(4,266,683) |
0 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • • |
2013-06-05 |
4 |
A |
$0.00 |
$0 |
I/I |
4,226,751 |
4,226,751 |
0 |
- |
|
| PGNY |
Progyny, Inc. |
Director |
– • – |
2020-08-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,805,847) |
70,293 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2019-01-22 |
4 |
D |
$75.00 |
$163,219,275 |
I/I |
(2,176,257) |
0 |
0 |
- |
|
| PGNY |
Progyny, Inc. |
Director |
– • – |
2020-11-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,992,097) |
0 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2012-07-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,970,443 |
153,695 |
0 |
- |
|
| PGNY |
Progyny, Inc. |
Director |
– • – |
2020-11-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,921,804) |
0 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • • |
2014-10-21 |
4 |
A |
$0.00 |
$0 |
I/I |
1,907,420 |
77,621 |
0 |
- |
|
| PGNY |
Progyny, Inc. |
Director |
– • – |
2021-01-07 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,887,938) |
56,444 |
0 |
- |
|
| PGNY |
Progyny, Inc. |
Director |
– • – |
2021-01-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,887,938) |
90,310 |
0 |
- |
|
| SGMT |
Sagimet Biosciences Inc. |
Director |
– • – |
2023-07-18 |
4 |
A |
$0.00 |
$0 |
I/I |
1,860,712 |
1,899,475 |
0 |
- |
|
| PGNY |
Progyny, Inc. |
Director |
– • – |
2021-06-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,836,821) |
29,494 |
0 |
- |
|
| PGNY |
Progyny, Inc. |
Director |
– • – |
2023-06-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,646,346) |
17,162 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2016-03-18 |
4 |
B |
$35.19 |
$49,999,993 |
I/I |
1,420,858 |
227,255 |
2.1 |
- |
|
| VERA |
Vera Therapeutics, Inc. |
Director |
– • – |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
I/I |
1,343,152 |
1,343,152 |
0 |
- |
|
| SLRN |
Acelyrin, Inc. |
Director |
– • • |
2023-05-09 |
4 |
B |
$18.00 |
$22,500,000 |
I/I |
1,250,000 |
9,790,729 |
2.25 |
% |
|
| PGNY |
Progyny, Inc. |
Director |
– • – |
2021-11-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,219,895) |
19,265 |
0 |
- |
|
| PGNY |
Progyny, Inc. |
Director |
– • – |
2020-08-19 |
4 |
A |
$0.00 |
$0 |
I/I |
1,078,340 |
1,078,340 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2017-09-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(929,949) |
0 |
0 |
- |
|
| PGNY |
Progyny, Inc. |
Director |
– • – |
2021-04-15 |
4 |
OE |
$1.73 |
$912,136 |
I/I |
527,246 |
8,823,142 |
0 |
- |
|
| PGNY |
Progyny, Inc. |
Director |
– • – |
2020-11-13 |
4 |
A |
$0.00 |
$0 |
I/I |
522,904 |
593,197 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
